as on September 4, 2025 at 1:29 am IST
Day's Low
Day's High
0.81%
Downside
1.44%
Upside
52 Week's Low
52 Week's High
53.25%
Downside
64.51%
Upside
Check Corcept Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.5B
EPS (TTM)
1.075
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.09%
PE Ratio (TTM)
63.7
Industry PE ratio
17.91
P/B Ratio
63.6964
PEG Ratio
0.61
EBITDA
102.6M
Revenue (TTM)
716.1M
Profit Margin
18.67%
Return On Equity TTM
21.70%
Track how Corcept Therapeutics Inc P/E has moved over time to understand its valuation trends.
Corcept Therapeutics Inc in the last 5 years
Lowest (17.91x)
September 30, 2020
Industry (17.91x)
September 4, 2025
Today (63.70x)
September 4, 2025
Highest (64.20x)
June 30, 2025
Today’s Price to Earnings Ratio: 63.70x
Compare market cap, revenue, PE, and other key metrics of Corcept Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $7.5B | 257.06% | 63.7 | 18.67% | |
BUY | $58.6B | 264.27% | -505.15 | -12.96% | |
NA | $39.4B | NA | NA | -3.89% | |
BUY | $101.7B | NA | 28.25 | 31.86% | |
BUY | $59.8B | -2.85% | 14.21 | 31.37% |
The Corcept Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Corcept Therapeutics Inc investment value today
Current value as on today
₹2,10,927
Returns
₹1,10,927
(+110.93%)
Returns from Corcept Therapeutics Inc Stock
₹1,06,008 (+106.01%)
Dollar Returns*
₹4,919 (+4.92%)
Based on 11 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Corcept Therapeutics Inc. Average target price of $134.5
Get share price movements and forecasts by analysts on Corcept Therapeutics Inc.
What analysts predicted
46.97%UPSIDE
Target Price
$134.5
Current Price
$71.32
Analyzed by
11 Analysts
Target
$134.50
Corcept Therapeutics Inc target price $134.5, a slight upside of 46.97% compared to current price of $71.32. According to 11 analysts rating.
Search interest for Corcept Therapeutics Inc Stock has decreased by -18% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 157.21M → 194.43M (in $), with an average increase of 19.1% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, 20.28M → 35.14M (in $), with an average increase of 42.3% per quarter
Best in 3 Years
In the last 3 years, CORT has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
In the last 1 year, CORT stock has moved up by 106.0%
Best in 1 Year
In the last 1 year, CORT has outperformed top 5 stocks with highest market-cap in its industry
Organisation | Corcept Therapeutics Inc |
Headquarters | 101 Redwood Shores Parkway, Redwood City, CA, United States, 94065 |
Industry | Health Technology |
CEO | Dr. Joseph K. Belanoff M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Amy Flood | Chief Human Resources & Communications Officer |
Mr. Roberto W. Vieira | President of Oncology |
Dr. Joseph K. Belanoff M.D. | Co-Founder, President, CEO & Director |
Mr. Sean Maduck | President of Endocrinology |
Dr. William Guyer Pharm.D. | Chief Development Officer |
Mr. Gary Charles Robb J.D. | Chief Business Officer & Secretary |
Mr. Joseph Douglas Lyon | Chief Accounting & Technology Officer |
Dr. Hazel Hunt Ph.D. | Chief Scientific Officer |
Mr. Atabak Mokari | CFO & Treasurer |
Ms. Monica Tellado | President of Emerging Markets |
Corcept Therapeutics Inc share price today is $71.32 as on at the close of the market. Corcept Therapeutics Inc share today touched a day high of $72.35 and a low of $70.74.
Corcept Therapeutics Inc share touched a 52 week high of $117.33 on and a 52 week low of $33.34 on . Corcept Therapeutics Inc stock price today i.e. is closed at $71.32,which is 39.21% down from its 52 week high and 113.92% up from its 52 week low.
Corcept Therapeutics Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Corcept Therapeutics Inc (CORT) shares with as little as ₹88.035 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.35 in Corcept Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Corcept Therapeutics Inc share’s latest price of $71.32 as on September 4, 2025 at 1:29 am IST, you will get 0.1402 shares of Corcept Therapeutics Inc. Learn more about
fractional shares .
Corcept Therapeutics Inc stock has given 257.06% share price returns and 20.11% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?